4//SEC Filing
Cory David A 4
Accession 0001140361-22-009256
CIK 0001305253other
Filed
Mar 10, 7:00 PM ET
Accepted
Mar 11, 9:06 PM ET
Size
7.0 KB
Accession
0001140361-22-009256
Insider Transaction Report
Form 4
Cory David A
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2022-03-11+281,000→ 281,000 totalExercise: $5.10Exp: 2032-03-10→ Common Stock (281,000 underlying) - Award
Common Stock
2022-03-11+47,000→ 169,183 total
Footnotes (3)
- [F1]Represents shares underlying Restricted Stock Units award that will vest as to 33.3% on each of the first, second and third anniversaries of the grant date of March 11, 2022.
- [F2]The option vests in 48 equal monthly installments commencing on the grant date of March 11, 2022, subject to the Reporting Person's continuous service as of such date.
- [F3]Includes shares purchased under the Issuer's Employee Stock Purchase Plans as follows: 1,378 shares on September 5, 2020, 1,459 shares on September 3, 2021, and 1,500 shares on March 5, 2022.
Documents
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeother
Related Parties
1- filerCIK 0001670137
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 7:00 PM ET
- Accepted
- Mar 11, 9:06 PM ET
- Size
- 7.0 KB